Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2022
Filter by date:
Showing 1107 press releases before 2022
-
Further update on US regulatory review of roxadustat in anaemia of chronic kidney disease
-
Tezepelumab is the first biologic to consistently and significantly reduce exacerbations in broad population of severe asthma patients
-
Voluntary withdrawal of Imfinzi indication in advanced bladder cancer in the US
-
IDMC has concluded that OlympiA trial of Lynparza crossed superiority boundary for invasive disease-free survival vs. placebo at planned interim analysis
-
AstraZeneca COVID-19 vaccine authorised for emergency use by the World Health Organization
-
Full-year 2020 results
-
AstraZeneca and IDT Biologika sign letter of intent to increase COVID-19 vaccine manufacturing in Europe and secure long-term supply capacity
-
Divestment of Crestor in Europe to Grünenthal completed
-
Update on KESTREL Phase III trial of Imfinzi with or without tremelimumab in the 1st-line treatment of recurrent or metastatic head and neck cancer
-
Forxiga approved in China for heart failure
Latest articles and press releases
All of our latest press releases and articles are available to explore
